Insiders · Profile

Galindo Alejandro

EVP Endocrine Business Unit at MANNKIND. Filing since 14 Nov 2018. CIK 0001821447

Company
Date
Role
Action
Shares
Amount
Of holding
22 Aug 2022
EVP Endocrine Business Unit
Sold, plan not stated
4,615
$17.77K
0.6%
31 Jul 2022
EVP Endocrine Business Unit
Bought
5,000
$14.65K
0.6%
28 Feb 2022
Chief Commercial Officer
Bought
36,900
$100.00K
6.8%
31 Jan 2022
Chief Commercial Officer
Bought
2,334
$7.40K
0.4%
30 Jul 2021
Chief Commercial Officer
Bought
5,000
$14.95K
0.9%
14 Nov 2018
Chief Commercial Officer
Bought
34,602
$100.00K
9.5%
6 decisions on file.